5-azacytidine-modified patterns of uridine kinase activities in normal and neoplastic tissues.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001374:Azacitidine / Q000494:pharmacology* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000201:enzymology; D004790:Enzyme Induction; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms / Q000201:enzymology; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology*; D010770:Phosphotransferases / Q000378:metabolism*; D051381:Rats; D013997:Time Factors
D000970:Antineoplastic Agents; D010770:Phosphotransferases; D001374:Azacitidine